4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000071
Senior Vice President, Finance sold 9,999 shares at an average $84.63 ($846,180)
- Senior Vice President, Finance acquired 9,999 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Agarwal Arjun · Senior Vice President, Finance
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,541 | $12.50 | $106,763 | 23,853 | D |
| 2026-07-13 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,458 | $34.39 | $50,141 | 25,311 | D |
| 2026-07-13 | Sale : show line 3 in the form 10b5-1 | −300 | $83.07 | $24,920 | 25,011 | D |
| 2026-07-13 | Sale : show line 4 in the form 10b5-1 | −3,743 | $84.26 | $315,369 | 21,268 | D |
| 2026-07-13 | Sale : show line 5 in the form 10b5-1 | −5,656 | $84.90 | $480,201 | 15,612 | D |
| 2026-07-13 | Sale : show line 6 in the form 10b5-1 | −300 | $85.63 | $25,690 | 15,312 | D |
| Open-market sales · 9,999 sh · avg $84.63 · $846,180 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-13 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −8,541 | 101,459 | D |
| 2026-07-13 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) | −1,458 | 61,250 | D |
Loading xslF345X06/form4.xml…